TrianglePUBLICATIONS · 22072535
Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Am J Hematol
- Publication date
- 2012 Jan
- First author
- Farhat H
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Farhat H
- type
- Author
- name
- Reman O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- Berthon C
- type
- Author
- name
- Pautas C
- type
- Author
- name
- Kammoun L
- type
- Author
- name
- Chantepie S
- type
- Author
- name
- Gardin C
- type
- Author
- name
- Rousselot P
- type
- Author
- name
- Chevret S
- type
- Author
- name
- Dombret H
- type
- Author
- name
- Castaigne S
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Farhat H
- type
- Author
- name
- Reman O
- type
- Author
- name
- Raffoux E
- type
- Author
- name
- Berthon C
- type
- Author
- name
- Pautas C
- type
- Author
- name
- Kammoun L
- type
- Author
- name
- Chantepie S
- type
- Author
- name
- Gardin C
- type
- Author
- name
- Rousselot P
- type
- Author
- name
- Chevret S
- type
- Author
- name
- Dombret H
- type
- Author
- name
- Castaigne S
- type
- Author
- bibliography ids
- nci-bib-56187c4ac35e8c3381712476
- book metadata
- content sha256
- 1fe32ab2f00e839a7fdb7c7db1dc4019493b656b18f2f7b1691cad81de26433a
- document type
- citation
- dois
- 10.1002/ajh.22201
- electronic publication date
- display
- 2011 Nov 10
- precision
- day
- year
- 2011
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:22072535
- immutable id
- pubmed:22072535@1fe32ab2f00e839a7fdb7c7db1dc4019493b656b18f2f7b1691cad81de26433a
- journal
- abbreviation
- Am J Hematol
- issn electronic
- 1096-8652
- issn print
- 0361-8609
- issue
- 1
- name
- American journal of hematology
- nlm unique id
- 7610369
- pages
- 62-5
- volume
- 87
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 22072535
- provenance
- batch id
- b6284687e167e7da9556
- provider
- NCBI PubMed ESummary
- record sha256
- aaac99f088d9cb05ca14cb6c2e990d2ced7850774ff6cbf4e3722a2fa30b138a
- response sha256
- 64d5b7bb63f574c559af2523b779a262267cbc8e8cd02a5b47f4193cc95cabd3
- retrieved at
- 2026-09-09T23:46:45.216259+00:00
- publication date
- display
- 2012 Jan
- precision
- month
- year
- 2012
- publication types
- Clinical Trial, Phase I
- Clinical Trial, Phase II
- Journal Article
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Fractionated doses of gemtuzumab ozogamicin with escalated doses of daunorubicin and cytarabine as first acute myeloid leukemia salvage in patients aged 50-70-year old: a phase 1/2 study of the acute leukemia French association.
Preserved source evidence · Not medical advice